Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 37,587,253	$ 33,146,725
Accounts receivable, net	6,049,501	5,277,250
Product deposit	136,755	485,850
Inventory, net	2,645,443	2,759,932
Other current assets	2,238,005	934,510
Total Current Assets	48,656,957	42,604,267
Non-current Assets
Equipment, net	1,420,052	476,303
Right of use assets	6,750,256	594,897
Capitalized software, net	13,457,432	11,795,979
Intangible assets, net	2,275,225	3,009,263
Total Non-current Assets	23,902,965	15,876,442
Total Assets	72,559,922	58,480,709
Current Liabilities
Accounts payable	15,867,469	11,084,855
Accrued expenses	21,013,174	13,937,494
Notes payable, net		327,597
Current operating lease liabilities	403,319	603,180
Current portion of long-term debt	5,277,778
Deferred revenue	16,390,541	8,828,598
Total Current Liabilities	58,952,281	34,781,724
Long-term Liabilities
Long-term debt, net	12,951,280	17,927,727
Noncurrent operating lease liabilities	6,511,425	73,849
Contingent consideration	100,000	131,250
Total Liabilities	78,514,986	52,914,550
Commitments and contingencies (Note 10)
Mezzanine Equity
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of September 30, 2024 and December 31, 2023
Stockholders’ (Deficit) Equity
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $25.55 per share as of September 30, 2024 and December 31, 2023	140	140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 41,909,572 and 38,358,641 shares issued, 41,806,532 and 38,255,601 outstanding as of September 30, 2024 and December 31, 2023, respectively	419,096	383,586
Additional paid-in capital	227,394,727	217,550,583
Accumulated deficit	(235,370,384)	(214,265,236)
Treasury stock, 103,040, at cost, as of September 30, 2024 and December 31, 2023	(163,701)	(163,701)
Total LifeMD, Inc. Stockholders’ (Deficit) Equity	(7,720,122)	3,505,372
Non-controlling interest	1,765,058	2,060,787
Total Stockholders’ (Deficit) Equity	(5,955,064)	5,566,159
Total Liabilities, Mezzanine Equity and Stockholders’ (Deficit) Equity	$ 72,559,922	$ 58,480,709